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Abstract  
Background 
The aim of this research review is to propose the logic and search mechanism for the 
development of an artificially intelligent automaton (AIA) that can find affected cells 
in a 3-dimensional biological system. Research on the possible application of such 
automatons to detect and control cancer cells in the human body are greatly focused 
MRI and PET scans finds the affected regions at the tissue level even as we can find 
the affected regions at the cellular level using the framework. The AIA may be 
designed to ensure optimum utilization as they record and might control the presence 
of affected cells in a human body. The proposed models and techniques can be 
generalized and used in any application where cells are injured or affected by some 
disease or accident. The best method to import AIA into the body without surgery or 
injection is to insert small pill like automata, carrying material viz drugs or leukocytes 
that is needed to correct the infection. In this process, the AIA can be compared to 
nano pills to deliver or support therapy. These small automatons nevertheless called 
as small pill-sized robots could then be inserted into the body via the mouth and then 
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made to search for all affected areas. We propose that affected areas can be found by 
means of an algorithm that uses artificial intelligence-based spiral search techniques 
in vertical and horizontal directions.   
Results 
We believe the automatons may be tracked and controlled externally using sensors, 
lasers or sonography, thereby controlling sensors present in them. Furthermore, this 
may be used to transmit information while probabilistic measures of location and the 
extent of infection could be rendered to each cell in a given area. NanoHive 
simulation software was used to validate the framework of this paper. The existing 
nanomedicine models such as obstacle avoidance algorithm based models (Hla K H S 
et al 2008) and the framework in this model were tested in different simulation based 
experiments. The existing models such as obstacle avoidance based models failed in 
complex environmental conditions (such as changing environmental conditions, 
presence of semi-solid particles, etc) while the model in this paper executed its 
framework successfully.  
Conclusions 
Come systems biology, this field of automatons deserves a bigger leap of 
understanding especially when pharmacogenomics is at its peak. The results also  
indicate the importance of artificial intelligence and other computational capabilities 
in the proposed model for the successful detection of affected cells. 
Background  
Introduction 
1.1 Cell is the basic unit of life 
A cell is the basic unit of life.  It is a complex system working independently as well  
as in symbiosis with its external environment (Bolsover et al 2003).  In humans, the  
cells are differentiated based on the functions they carry out. For example, the red 
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blood cells (RBC) or erythrocytes, leukocytes, lymphocytes etc. It is believed that   
several cells metamorphose to different functions for example, transmission of  
electrical signals is done by neurons, transport of oxygen by red blood cells,  
destruction of infecting bacteria through macrophages, contraction by muscle cells,  
chemical processing by liver cells etc. 
 
1.2   Intelligent tools are required to combat cellular infection 
More background is needed why automatons are a must and what role they may have 
to play.  
 
1.3 What are Automatons? 
A nano-sized artificially intelligent robot that can investigate biological environment 
is termed as automaton. Automatons are singletons and .are made of??? . On the other 
hand, the micro-motor approaches s automaton in structure and functionality (Friend 
2009) which therefore can be made artificially intelligent to execute the course of 
action. First, cellular infections generally spread in clusters or in roughly circular 
regions.  
 
Applications of automatons: 
1) The automaton is used to move into the body and detect any affected cells.  
2) This automaton can be very useful in drug-delivery. 
 
Objectives of our study: 
1.     Dead human bodies or small animals (resembling humans in their body structure  
        and functions) will be used as subjects rather than live humans.  
2.    The framework will be first implemented on a part of the body e.g. the gastro- 
intestinal track. Again, we will try to employ multiple automatons here to reduce 
the time lag in recording the information. Also, it is possible that the entire 
automaton may not be able to detect all the cells in the region as each region is 
very dynamic and difficult to track. The gastro-intestinal track is a difficult terrain 
to walk through the gastro-intestinal track lumen and thus all cells may not be able 
to scan all the cells. IN such cases, it is advisable to divide each region for separate 
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automaton for scanning the region. Thus, for each different type of terrain of the 
region, a different automaton will be used. 
3. The automaton will move along a linear trajectory. However, the search 
mechanism used by the automaton will follow the algorithm described below. In 
this paper, any reference to search mechanism will mean the search mechanism of 
the automaton and not its movement. 
4. The automaton will have high resolution cameras that will be able to scan in all 
directions, especially in a circular fashion, while it moves forward recording the 
cellular details of the region. In short, while the movement of the automaton will 
be linear, the movement of the cameras of the automatons or any of its parts used 
in recording cellular details will be circular, in horizontal and vertical directions. 
This is because body parts generally have closed cylindrical structures. 
5. Please note that detection and analysis of each cell will take time and the scan of 
the entire region will be very time-consuming. Thus, it can be useful to employ 
multiple automatons to scan each region independently. 
6. It is possible that one type of infection might share similar traits with another 
infection. Thus, it will be very important for the automaton to have knowledge of 
2-3 unique features of each infection. This will help it to record information for 
each infection clearly. 
7. The automaton will be embedded with artificial intelligence and logic so that it can 
perform its expected work without any human interference.  
 
Freitas (Freitas R. 1999, Nanomedicine) pioneered the concept of nanomedicine, 
when he published the first design on nanorobot. He has extensively covered several 
aspects in Nanomedicine in his work, including inter-nanorobot communication, 
locomotion and applications. He has thrown light on biocompatibility issues in 
Nanomedicine too. The use of an artificially intelligent automaton is a step towards 
extending the work on Nanorobotics that has been done by Freitas, Cavalcanti and 
other eminent experts in this field. Cyril Ng (Cyril Ng et al 2008) has suggested the 
use of nanorobots in the tracking/treatment of targeted cells in the body. There is a 
need for models (Gutierrez 2009) that can help us find and analyze all the affected 
cells in the human body. Such models are very important for the efficient use of AIA. 
According to Sitti (Sitti .M. 2009), the future challenges in developing micro-robots 
include finding methods for interacting with them inside the body.  Zhang (Zhang et 
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al 2009) have reported artificial bacterial flagella that simulate their natural 
counterparts and swim in blood. Cavalcanti (Cavalcanti A. et al ICARCV 2006) have 
proposed the use of a nano-robot that uses a “follow gradient with attractant signal” 
method to detect cancer cells. Witten (Witten 1989) has discussed the growth 
modifying factor (GMF) in detail in order to show its impact on cancer growth.  
Codourey (Codourey et al 1994) had proposed the design of nanorobots with focus on 
high accuracy and reduction of overall dimensions. Cyril (Cyril Ng et al 2008) has 
emphasized on the use of Evolutionary Nanotechnology in biological applications 
using artificially intelligent materials. Cavalcanti (Cavalcanti A., Shirinzadeh B., et al 
AWFM06 2006) has proposed a framework for nanorobots hardware in laparoscopic 
cancer surgery. He also mentions that Preoperative lymph node staging with 
computerized tomography or magnetic resonance imaging (MRI) was not successful 
as sensitivity and specificity are limited. Zesch (Zesch .Z., Buchi R., et al 1995) and 
colleagues have discussed two piezoelectric devices for positioning in the nanorobot.  
Mallouk (Mallouk T. et al) presents a nano engine that was two-micron-long gold-
platinum rods which could move ahead in a solution of water and hydrogen peroxide 
(H2O2) by pushing the fluid along their sides. Greitmann (Greitmann G. et al 1996) 
proposes a micro machined gripper system with integrated sensor and actuator. 
Cavalcanti (Cavalcanti A. 2005) has emphasized the need of automation of atomic-
scale manipulation in nanotechnology applications. Ferreira (Ferreira A. et al 2005) 
and colleagues have suggested the use of simulated nano-environments in virtual 
technologies. Requicha (Requicha A. 2002) initially discusses the construction of 
nanorobots and then later focuses on nanoassembly by manipulation with scanning 
probe microscopes (SPMs). Duncan (Duncan R. 2004) discusses the possibility of 
nanotechnology applications in the treatment of diseases. The author too proposes the 
concept of nanorobots being used for drug-delivery and that this could be practically 
implemented in future. Casal (Casal A. et al 2003) discusses the concept of a 
nanorobot in a simulated microenvironment that can move in semi fluid areas. This 
nanorobot simulator uses a set of design parameters. Cavalcanti (Cavalcanti A. et al 
2006) have proposed an excellent computational method for developing nanorobots in 
liquid environments, using Reynolds number, for medical applications like drug-
delivery and surgery. Sitti (Sitti M. 2009) has talked about nanobots or tiny robots that 
can be injected into the body to perform medical procedures. Setti also cites the 
importance of methods for the nanorobots to be used effectively in biological systems 
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for medical applications. Hamdi (Hamdi et al 2006) proposes a simulation for bio-
nanorobotic prototyping using NAMD software and VR techniques. The authors 
propose to use these biomolecular motors for manipulation and structuring at the 
protein level. In an innovative paper, Lewis (Lewis et al 1992) has proposed a method 
for coordinated control of a large number of nanorobots. Sudo (Sudo et al 2006) have 
proposed a magnetic swimming mechanism in nanorobot development. The 
movement of proposed robot is via the oscillation of its tail. The authors also mention 
that the miniaturization of the permanent magnet is needed for the robot to move 
through the smaller capillaries. In their reply to the doubts raised by Curtis (Curtis A. 
2005) on their paper, Cavalcanti (Cavalcanti A. and Freitas R. 2005) have mentioned 
the development of digital circuits in living cells. In an excellent paper, Bedau (Bedau 
et al 1997) propose a quantitative comparison of such trends in model systems and in 
the biosphere. Cavalcanti (Cavalcanti A. and Freitas R. Aug 2002) have proposed the 
design and simulation of a team of multipurpose nanorobots for activities like 
nanomedicine delivery at affected cell regions. Brunner (Brunner M. and Stemmer A. 
1998) has suggested the design and control of a nanorobot with 2 - dimensional linear 
motor and AFM (atomic force microscope) for image processing of affected regions. 
In another excellent paper, Alouges (Alouges F. et al 2007) has proposed a numerical 
algorithm to compute optimal strokes for swimming of artificial micro-swimmers. 
However, they also emphasize the need for more mathematically abstract tools for 
biological swimmers. Ion (Ion R. and Cocina G. 2008) in their paper studied the 
controlled aggregation of meso-5, 10, 15, 20-sulfonato-phenyl porphyrin (TPPS4) at 
room temperature. using electron microscopy (SEM), transmission electron 
microscopy (TEM) and UV-visible spectroscopy. The authors have used nanorobots 
for application in brain aneurysm. Saniotis (Saniotis 2008) discusses the future 
applications of nanotechnology. He throws light on nanocosms, Respirocytes and 
microbovores as possible future examples of use of nanotechnology. Freitas (Freitas 
.R.2003) has pioneered the concept of respirocytes and microbovores in the field of 
nanomedicine. Hla (Hla et al Nov 2008) in his paper has proposed the particle swarm 
optimization algorithm (PSO) besides obstacle avoidance to control nanorobots 
movement in the human body. The authors propose a 2-dimensional coordinate 
system to implement the obstacle avoidance algorithm. Pitt (Pitt J. 2008) discusses the 
possibility of self-replicating nanorobots that could cause unwanted harm for the 
human race. Cavalcanti (Cavalcanti 2003) has proposed a noel approach in nanorobot 
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control design for assembly manipulation using graphical simulations. Again with this 
co-authors (Cavalcanti et al CIMCA 2006), he proposes the use CMOS based chips 
for the manufacturing nanorobots.  
 
Methodology 
2.1   Framework explanation 
First, there is a need to ensure the better functioning of AIA, which is the primary 
motivation for this paper. It is also necessary to create a support mechanism that will 
enable AIA to be used for delivering more effective treatment to patients.  
We consider cells as points, represented in Cartesian coordinates by P(x, y, z) where x 
is the length, y is the breadth and z is the height of the cell location in a three-
dimensional human body map. The automaton then assigns a probability, called the 
Cellular Infection Probability Measurement (CIPM), that the cell being affected.  
Cellular representation and comparisons require mathematical techniques to identify 
the affected regions in the body. As the cells are analyzed by the automaton, the 
resulting information can be plotted in a graph. This will be a two-dimensional graph 
called the Cellular Infection Probability Graph (CIPG). This graph can be plotted with 
its X axis showing the cell location P(x, y, z) and the corresponding Y axis showing 
the probability (CIPM) of that cell being affected.  
For each cell point under investigation, there is a measurement assigned called 
Cellular Infection Level Measurement (L). This level gives a value of the degree or 
level of infection present in the cell. This degree of infection is found by finding the 
average of the values for attributes of the infection determinants (on a scale of 1-10) 
like color, cell width, cell height, cell length, presence of unwanted particles or 
pathogens, etc. As any cell has more than one trait (like cell color, enzyme content 
‘XYZ’), we denote it by Ln, m, where m is the index of the trait for the cell n. Each 
trait is measured on a scale of 1-10 and then the average of all the trait measurements 
is taken to get the Average L (Avg (Ln)) value. Here, the measurements of each trait 
Ln, m and Avg (Ln) is taken. For simplicity, we will refer Avg (Ln) as Ln.  
Please note the difference between the two measurements, CIPM and L. CIPM is the 
probability of finding a cell as being affected.  For e.g.) when the automaton finds a 
cell point, it has to decide its type i.e. healthy type of cell or affected type of cell. The 
automaton will have a sample of the affected cell and based on this sample (or 
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knowledge of this cell that could be stored in its memory), it can make a comparison.  
It will assign a probability that this cell has a 0.4 or 0.8 probability of being affected. 
This is similar to the case when a doctor tells the patient that the patient has 40% or 
80% probability of survival after the operation.  This measure has been kept to let us 
know which cell is probably affected and which is not. 
L is a different measurement. It measures each of the actual traits of the cell like cell 
colour, protein content, etc. These traits need to be measured too in order to give us 
more information about the cell. This information allows better choice of treatment.  
This paper should help the development of better implementation and optimum 
utilization of AIA in the body. To achieve this goal, mathematical and computational 
techniques have been employed.  
It is evident that AIA need to be incorporated into the body orally or via injections. 
However, to ensure that these automata reach the affected regions in the best way 
possible, we need to deploy an automaton (next-generation pill with its own logic i.e. 
a robot), that can carry and control the entire process of material transfer and damage 
repair. For e.g.) .Also, we need to ensure that the patient undergoes minimum pain 
and stress due to the incorporation of AIA. Using recent advances in robotics and 
micro-technology, we can easily embed the necessary logic into the transporter, which 
will be of the size of a pill. The automaton will be controlled externally via using 
sensors or chips present in it. We can control and command the automaton and see 
how it is working inside the body. We could call such automata next-generation pills, 
as they can control and improve the logic and manner using the requisite material. 
The entire framework can be represented in the following steps (Figure - 6):- 
1. Travel in the 3-dimensional biological system and study each cell one by one. 
2. For each cell n, measure the probability CIPM (or Pn) that the cell is affected.  
3. Based on the value of P (n), we get the value of Ln, m. Pass on the values to the 
database. This database is outside the biological system for our records. 
4. In the graphs CIPG and CIWG being calculated, plot the cell’s P (n) and Ln, m 
for each type of affected cell found. 
5. Pass the treatment material from the automaton to the affected cell or trigger 
the repair mechanisms for the same. 
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6. Send the feedback or any other details to us (external environment) for our 
records. The logic and direction for the automaton can be updated or changed 
as per our needs. This includes any exception handling. 
7. Repeat the steps from Step-1 to Step-6 for each cell. Send any information 
needed to be given to the automaton for recording further cells. 
Techniques like Laparoscopic and Open Colorectal Surgery are possible methods for 
use in this framework. Braga and colleagues (Braga et al 2002) have experimentally 
shown that laparoscopic surgery is better than open surgery. However, capsule 
endoscopy is proposed here as it is involves the use of camera like pills for studying 
the affected regions. Capsule endoscopy is a technique in which a small pill-like 
camera is injected into the human body. This pill-like camera then takes pictures of 
the internal regions of the body. This technique is widely used in obtaining images of 
the gastro-intestinal track. The automatons can be fitted with such high-resolution 
cameras for scanning each cell. 
The modelling of the biological system (human body) is important as it gives us an 
idea about the expected location and possible type of cell at each point. Thus, we can 
safely deduce that if there is a possible dislocation or deviation of the expected cell 
found by the automaton at that point, then it is possible to find an affected 
cell/external agent at that point. 
 
2.2   NanoHive and simulation based experiments 
As shown in figure 7, NanoHive simulation software was used to validate the 
framework of this paper. IBSEAD (Dundas .J. and Chik D. 2010) and adaptive neural 
networks were used as machine learning algorithms to help provide the intelligence in 
this framework. The existing nanomedicine models (such as obstacle avoidance based 
model) and the framework in this model were tested in different simulation based 
experiments. Obstacles were introduced in varying capacities to test how the 
automaton would perform in the framework.  
The use of IBSEAD is justified as the presence of complex environments requires the 
handling of unknown entities, which is not done by other machine learning 
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algorithms. The experiments were carried out using proven simulation software based 
scenarios, after an initial round of dry-run algorithmic analysis of the scenarios. 
Discussion  
Search Mechanism for Automaton to find affected cells in the body 
Any cell can be distinguished from all others on the basis of its location and 
functionality. In order to find the affected cells, we need to treat the human body as a 
3-dimensional biological system. The human body (Gray 2005, B J C Perera 2004) is 
symmetrical but complex in structure, and needs a three-dimensional approach to 
structural analysis. Every point or cell in the body is identified in terms of its x, y and 
z coordinates. These correspond to the distance of the cell (from the origin O) in the x, 
y and z directions. Thus cell P is given by P(x, y, z). Now, the search mechanism for 
affected cells cannot be executed linearly, since those affected cells do not spread and 
are not organized linearly. They are randomly distributed and thus need to be searched 
using an algorithm that takes account of such randomness (Figure-3). The internal 
regions are mostly cylindrical in structure like a hollow pipe. Thus, the cells have to 
be tracked initially in a vertical (standing) spiral-like movement, like a roller coaster. 
However, we also need to know whether an affected cell is isolated or part of a bigger 
cluster of affected cells. A probability of infection can be assigned to each cell, the 
Cellular Impact Probability Measure (CIPM), by comparing the sample of affected 
cells. We also need to know the degree or extent of infection in the cell. This can be 
obtained by studying attributes (colour, size, thickness, materials present, etc.) and 
finding the extent to which each differs from the healthy cell. Each Ln, m is measured 
(scale 1-10) and then an average of all attributes is obtained. This measurement will 
be called Cellular Infection Level Measurement (L) for any cell. It is also denoted by 
Ln as shown in the previous sections. The CIPM and L tell us if a cell is affected and 
define the type or extent of infection. Any region may have two or more types of 
infection, so these measurements will give us information about the number of 
affected cells and the type of infections present in a region. The grading systems 
(Schulz 2005) for measuring the malignancy of cancer like ‘G Grading ’, can be 
customized for serving the same purpose in this model. The L can include the values 
like those from ‘G Grading’ system for measuring the malignancy of the affected 
cells. 
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As diseases such as cancer generally occur in clusters, it would be better to track 
affected cells in clusters. Thus, when an affected cell is found, the search method will 
change. It will now become a spiral-like search with horizontal movement. The 
starting point will be the currently tracked affected cell; taking this as the centre, the 
search will proceed spirally in a horizontal direction. This will help to find clusters of 
affected cells, if any, in that region. The following steps (Figure-3) outline the method 
by which the automaton will locate and record the affected cells in the human body. 
1.  Spiral search in vertical direction:- 
2. Spiral search in horizontal direction:- 
These steps have been explained with an example in the supplementary material,  
showing both the types of search algorithms working in sync to detect the affected  
cells. The spiral search in vertical direction will in execution till the first affected cell  
is detected by it (Pn > 0.5). Once this happens, the spiral search in horizontal direction  
will start executing, with the process executing till the cells that are detected become  
non-affected i.e. Pn < 0.5. Once this happens, the spiral search in vertical direction is  
started again from the point where it had left. Please note that this includes ignoring  
the cells that have already been scanned and recorded. Further details are present in  
the example mentioned in the supplementary material of this paper. 
Once all the cells have been studied and their probabilities measured, we can create a 
graph (CIPG) to reflect the spread and impact of the affected cells and their 
underlying cause. A two-dimensional graph (Figure.-2) can be plotted with the x 
coordinate showing the cell location P and the corresponding y coordinate showing 
the probability measure (CIPM or Pn) of that cell being affected or injured. The 
graph will portray the number of affected regions and the extent to which cells are 
affected throughout the body. This is very useful in finding the location and type of 
cancer cells in the body. As cancer is difficult to predict and track, this model can be 
very useful in the control and treatment of the same. 
Also, for each point under investigation, there is a level assigned called cellular 
infection level(L). This level gives a value of the degree of infection present in the 
cell. This degree of infection is found by finding the average of the values for 
attributes of the infection determinants (on a scale of 1-10) like colour, cell width, cell 
height, cell length, presence of unwanted particles or pathogens, etc. We also need to 
measure each of the traits measurement like Ln,m where n is the cell and m is the each 
of the cell trait. This measurement Ln,m is taken for each cell trait.  Later the average 
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of each of these traits is taken to achieve Avg Ln (or L).  For e.g. if there is a cell with 
n=12340(index of the cell) and coordinates P(100,200,300 ) ,  then we represent the 
cell by W12340. Assuming that the cell ‘n’ is having CIPM (or P(12340) = 0.7. Let us 
consider the traits like cell colour and enzyme ‘XYZ’ (assumed name) content. Thus 
‘m’ will have index values 0 to 1. Thus, we have cell colour trait as W100,0  =  0.7 and 
enzyme ‘XYZ’ content as W100,1  =  0.6. We can extend ‘m’ as per the number of 
traits considered for the cells. Thus, the average of cell n=12340 is given by:- 
W12340 = (0.7 + 0.6) / 2 = 1.3 /2 = 0.65. 
This will help us to propose better, methods and techniques of treatment to control the 
affected cells for the underlying cause. Doctors and other experts will obtain a better 
picture of the disease or infection, enabling to prescribe better medications and 
management procedures for the patient. 
There is a point to be noted in this search algorithm. It is possible that a cell that was 
recorded in the horizontal direction based spiral search is again found in its path. In 
such a condition, such a cell is just skipped by the automaton and the search proceeds 
to the next cell. For e.g.) suppose that a cell (10, 20,100) was encountered by the 
automaton in the horizontal search and it is recorded as affected with a cellular 
infection probability of 0.6. When the vertical direction based spiral search is 
encountered again by the automaton in its path, then this cell is skipped by the 
automaton. Thus, the search proceeds ahead with the next cell. 
It is also possible that there are two or more types of infections or external objects 
(particles, pathogens, etc) present in the area of investigation. Thus, there is a chance 
that the automaton may not be able to decide if such an object or affected cell is 
actually affected or healthy. The automaton can decide based on the comparison 
between the affected cell and the sample of the healthy cell that was in the beginning 
of this framework. Thus, in such a case, the points in the investigation area are 
assigned a probability of zero and the cellular infection level as per the values 
obtained by the automaton. The CIWG graph will show the actual values based on the 
measurement obtained by the automaton. Thus in the CIPG graph, such a cell is 
present on the X-axis (Figure – 5). Also, any new affected cell or external object must 
be recorded on a separate CIPG graph, with the curve beginning from the point where 
it was found. Thus, when such a new infection is recorded, the automaton will 
compare the current cell against the two sample cells (or objects). It will first compare 
the current cell against the original sample of the cell and record the impact and other 
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details on the CIPG graph. It will again do the same for the new type of affected cell 
or the external object. Thus, two curves will be plotted against the cell points in the 
CIPG.  Also, for every cell that is found to be of the second type of infection, we can 
assign a cellular infection probability of zero on the first curve. This value of zero will 
tell us that the cell at this point is of the second type of infection.  
This adjustment of creating a new curve on the CIPG is essential in understanding the 
possible relationship between the two types of infections (or objects) present in the 
investigation area of the body. For e.g.) the first type of infection maybe an infection 
in the urinary tract, while the second type of infection cell may be a small calcite 
stone in the kidney. Thus, plotting two CIPG graphs will give us an idea of:- 
1. How many affected cells of each type are present in the area of investigation? 
2. What is the possible relationship between the types of affected cells? 
 
It is also possible that the cell may have both types of infection present on it. For e.g.) 
a cell showing a pus cell may have a kidney stone particle engulfed in it. Thus, both 
these cells will be assigned the same cellular infection probability. Such a case clearly 
implies that there is relationship between the two types of infection found in the cell. 
For e.g.) a kidney stone particle can cause an infection in the urinary tract. Also, 
continuous problems in digestion or lung-related issues may point to stomach or lung 
cancer respectively. 
This adjustment in the search mechanism can be generalized to include more than two 
types of infections in the investigation area. The method of recording the different 
types of infection will remain the same as shown in the above paragraph. Such an 
adjustment can help us find the root cause of infection or medical condition in the 
patient. This will in turn help us find the most suitable treatment of the patient. 
In this paper, the information that is collected (Pn and Ln, m) by the automaton is stored 
in a database. This information can be analyzed t obtain critical insight into the 
condition of the cell. 
It is also possible that the automaton may face an external agent or obstacle in its 
pathway. In such a case, the automaton will treat this agent or particle as a new type 
of affected cell and thus it will create a separate curve on the CILG graph for the 
same. Also, it may be possible that the automaton may face an issue or obstacle in its 
path. In such cases, it can communicate with us via the sensors for directions.  
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Measuring the traits of the cells 
Each cell is made up of several traits in the body. For finding if the cell is affected or 
not, we need to measure each cell to know the level to the cell has been affected. In 
order to calculate the value L for each cell. We need to have generalized formulae to 
do so.   
Lets us consider a cell L1,m, L2,m,  …….. Ln,m..  If we consider that each cell has 10 
traits that could cause or indicate cancer. Some of these include oncogenes content, 
cell colour, etc. Thus, each of them would be having their own scale of measurements 
such as kg, mtr, etc. Thus, these unites have to converted into relative 1-10 scale to 
make them in sync with the framework and thus comparable with other cell traits. 
Once all the traits are measured, their average can be found to obtain Ln. This average 
is shown along with the individual traits as curves on the CILG graph to get a clear 
picture of the cell conditions in the body.  
It is a very important to note that the traits that are to be measured may be difficult to 
convert into relative 1-10 scale.  These traits may be in decimals to retain the accuracy 
in calculation. Thus, the conversion procedure needs to be tested and verified before 
being used with this framework. 
 
 Design of Automaton 
It is proposed that the automaton be designed on the lines of the structure of the sperm 
cell. The sperm cell (Gray 2005) is one of the most fantastic cells that can travel a 
long distance on its own towards its target. Next, it also pierces into the egg cell and 
releases its chromosomes into the egg. This is a very interesting model used by the 
sperm cell and the automaton of this framework is inspired from the same.  
The automaton will have a sperm-like structure with the head containing the camera, 
radar and processing unit. The camera will be used for scanning and detecting 
affected cells. The radar will be used for tracking and capturing the signals from other 
automatons if needed.  It is also proposed that the automaton should be made capable 
of capturing any errors in cellular signalling. With the future advancement of 
nanotechnology, this automaton will hopefully be able to provide correction signals 
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for removing any errors in cellular signalling. The processing unit will be responsible 
for handling the decision-making and instruction execution for the automaton. The 
middle part of the automaton will consists of the engine for navigational propagation, 
communication equipment and medicinal material to deliver to the affected cell. The 
communication equipment will consist of processing the incoming signals from the 
radar and sending the signals to the other cells via the radar as well. One point of 
debate still revolves around the choice of electrodes for creating fuel for the 
automaton. In some previous scholarly papers, gold electrodes have been proposed. 
However, the choice still remains with the scientist executing this framework. The tail 
of the automaton will act as a propellant for propagation. The automaton will have to 
be highly connected so that communication between its counterparts as well as 
external cells and pathogens can happen without any problem. 
The body of the automaton should be biodegradable so that even on self-destruction, 
it will not harm the body.  Once the automaton will reach the affected cell, it will have 
to release the medicine for treatment. Again, after its task is completed, the automaton 
will be released from the body along with the body waste material. The automaton 
must degrade into powdered granules so that the particles can be released from the 
body without any problems for the host body. The locomotion of the automaton, 
driven by the tail and the directions from the head of the automaton, will help in the 
free movement of the latter. Again, the automaton will move in the manner of a 
snake-like movement with a zigzag-body movement based form of locomotion. This 
will resemble a snake moving on sand and the speed will be highest if the head of the 
automaton is smooth enough to cut through the liquid of the hosy body. Please note 
that the automaton’s head has to be very strong as it will encounter the maximum 
hurdles and direct accidents with the obstacles in the automaton’s path. 
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There may be a need to deploy multiple automatons with each automaton working in 
a specific region of the body. Thus, multiple networks based architecture, with each 
network having multiple automatons, is proposed for this framework. Here, each 
network of automatons will work in a specific region. There will be a controlling 
automaton that will control the other automatons in the network. 
The automaton will have the tip part of the former filled with poison or necessary 
weapons in order to fight the pathogens or other unwanted obstacles that cannot be 
avoided, negotiated or compromised. 
It is not necessary that the framework must follow the design of the automaton 
mentioned in this paper. The framework can be deployed for any automaton design 
that could be available at the time of execution of the same. Also, the design of the 
automaton can be further enhanced using the existing advances in nanotechnology. 
The automaton (Figure-6) maybe given the ability to self-detect and evolve to become 
smart enough to analyze the host body environment. The automaton will need 
artificial intelligence and other search methods to record all the stored data. The 
automaton will also benefit from the processing of information made available from 
the analysis done previously so as to help make better decisions in its execution of 
current responsibilities. 
 
Advantages and Support for Argument:- 
1. The mechanism by which the automaton searches for affected cells cannot be  
            executed linearly, since the affected cells are not spreading. They are  
            randomly distributed so they need to be searched using an algorithm that takes  
            account of such randomness. 
2. This method takes into account the presence of clusters of affected cells and  
 also those cells those are minute and isolated. Both these extreme cases will be  
 addressed. 
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3. This paper seeks to identify the best way to employ the AIA or other types of  
            cells, in resolving and preventing the problems of cancer cells and their  
            spread.  
4. Other methods employed for searching for affected cells do not use such a  
            combination of linear and spiral techniques. They tend to focus more on linear  
            and tree-based A.I. techniques. 
5. This paper outlines those aspects of support that tend to be overlooked or  
            minimized during Artificial Intelligence research.  Both the mechanism and  
            the usage procedure should be considered equally if the problem and its cure  
            are complex. 
6. This paper also allows us to record and analyze the root cause of the infection 
            present in the body.  
7. This will help us in better treatment for the patient. 
Results  
The results indicated that the use of machine learning concepts helped in improving 
the performance of the automaton by in complex environments and in the presence of 
dynamic obstacles. The existing models such as obstacle avoidance based models 
failed in complex environmental conditions (such as changing environmental 
conditions, presence of semi-solid particles, etc). Moreover, the information 
collection and self-adaptation helped this framework helped the automaton to change 
its behaviour, especially in the presence of obstacles. When the obstacles were found, 
the automaton (using IBSEAD and adaptive neural networks as machine learning 
algorithms) learned about the obstacles while avoiding them at a comfortable 
distance. When another similar obstacle was found, the automaton used the past 
experience and knowledge to handle the situation. This predefined ability to handle 
situations and obstacles were an important aspect in the success of the framework. As 
shown in figure 8, the results indicate the higher success ratio of the paper’s 
framework when compared with other learning algorithms. Moreover, the used of 
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analysis and graphs such as CIPM helped in better coverage and detection of 
multivariate affected cells. Thus, the framework in this paper is found to be much 
better in performance than the existing models. 
This theoretical paper is intended to enhance the function of AIA by defining the 
carrier framework and the search for identifying all the affected cells in the body. 
There are applications to cancer as well as to traumatic accidents to the body. In 
future, this framework can be extended to study and analyze the internal working of 
any cell. Also, it can be extended to study of the adaptation techniques in the internal 
parts of cells using automata. This framework may be utilized productively to analyze 
mutations and find mechanisms for repairing them. MRI and PET scans can find the 
affected regions at the tissue level.  
However, we can find the affected regions at the cellular level using this framework. 
It would be interesting to study the framework under a 4-dimensional biological 
system. The fourth dimension in this system will be time (in seconds). Thus, we can 
get the analysis of the cells in the human body at different points in time. 
There are several enhancements in this framework that can be implemented to make 
its utilization eve better.  
This design can be further enhanced by adding repair and medical-support 
system logic into it. Thus, based on information from the graph, decision 
support systems for doctors and biologists (to suggest prospective repair and  
solution strategies and mechanisms) can be integrated to aid in the treatment  
of the patient. 
The automata will perform several activities, of which the main ones are (Figure-1).  
This framework has many possible applications. It can also be used to remove 
thrombi. It can help us obtain clear images using Magnetic Resonance Imaging (MRI) 
and Positron Emitting Tomography (PET). In addition, the automaton can be 
modified with devices to remove affected cells or carry materials for treatment. One 
example would be the detection and removal of cancer, which is generally difficult 
with current medical treatment. 
The application of oncogenes (Crocker et al 2003) in the treatment of some cancers 
can be aided with the help of this model. Changes in the oncogenes can lead to cancer. 
This can happen through a number of mechanisms that are not unique to any one 
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gene. These mechanisms can be due to alteration in the protein itself, over-expression 
of the protein, or loss of control mechanisms. We can study these mechanisms and 
analyze how they can be stopped or reversed, in order to treat cancer. 
 
Other applications include the removal or treatment of following diseases: 
1. Dissolving clots caused in the “cholecystitis”. 
2. Removal of small abnormal tissue segments in uterine fibroid disease. 
3. Removal of thrombi resulting from deep vein thrombosis.  
4. Treatment of “oesophageal varices” by applying the oxidant agent, used for 
treatment, via the automaton. 
This paper is intended to enhance the function of AIA by defining the carrier  
framework and the search for identifying all the affected cells in the body. There are  
applications to cancer as well as to traumatic accidents to the body. In future, this  
framework can be extended to study and analyze the internal working of any cell.  
Also, it can be extended to study of the adaptation techniques in the  
internal parts of cells using automata. This framework may be utilized productively to  
analyze mutations and find mechanisms for repairing them. MRI and PET scans can  
find the affected regions at the tissue level.  
However, we can find the affected regions at the cellular level using this framework. 
It would be interesting to study the framework under a 4-dimensional biological 
system. The fourth dimension in this system will be time (in seconds). Thus, we can 
get the analysis of the cells in the human body at different points in time. 
 
Conclusions  
This paper is intended to enhance the function of AIA by defining the carrier 
framework and the search for identifying all the affected cells in the body. There are 
applications to cancer as well as to traumatic accidents to the body. In future, this 
framework can be extended to study and analyze the internal working of any cell. 
Also, it can be extended to study of the adaptation techniques in the internal parts of 
cells using automata. This framework may be utilized productively to analyze 
mutations and find mechanisms for repairing them. MRI and PET scans can find the 
affected regions at the tissue level.  
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However, we can find the affected regions at the cellular level using this framework. 
It would be interesting to study the framework under a 4-dimensional biological 
system. The fourth dimension in this system will be time (in seconds). Thus, we can 
get the analysis of the cells in the human body at different points in time. 
Terms and Definitions 
1. n: - It is the cell represented by the coordinates x, y and z. 
2. O: - It is the point of origin in the 3-dimensional biological system. 
3. x: - It the distance of the cell ‘n’ in the X-axis of the biological system. 
4. y: - It the distance of the cell ‘n’ in the Y-axis of the biological system. 
5. z: - It the distance of the cell ‘n’ in the Z-axis of the biological system. 
6. m: - It is the index of the trait of the cell. For e.g. there are several traits of cell 
like cell colour, enzyme content, etc. Each of the ‘n’ cell traits is indexed by 
‘m’. 
7. CIPM: - Cellular Infection Probability Measurement. The automaton then 
assigns a probability, called the Cellular Infection Probability Measurement 
(CIPM), that the cell being affected. It is also denoted by Pn. 
8. L: - Cellular Impact Level Measurement. For each cell point having more than 
one trait under investigation, there is a measurement assigned called Cellular 
Impact Level Measurement. This measurement is 2-dimensional for each trait 
as it is indexed by the cell position ‘n’ and the cell trait ‘m’ i.e. it is measured 
for each cell trait. This measurement gives a value of the level upto which the 
cell is affected. As any cell has more than one trait (like cell colour, enzyme 
content ‘XYZ’), we denote it by Ln, m, where m is the index of the trait for the 
cell n. Each trait is measured on a scale of 1-10 and then the average of all the 
trait measurements is taken to get the Average L (Avg (Ln)) value. Here, the 
measurements of each trait Ln, m and Avg (Ln) is taken. For simplicity, we will 
refer Avg (Ln) as Ln. 
9. CIPG: - Cellular Impact Probability Graph. The graph shows the values of 
CIPM (or Pn) for each cell ‘n’.  
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10. CILG: - Cellular Infection Level Graph. The graph shows the values of L (or 
Ln, m) for each cell ‘n’. In this graph, the measurements of each trait Ln, m as well 
as Ln   is represented on a separate curve. 
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Search and record information about all the 
affected cells and the regions in which they are 
present 
Assign a probabilistic measure of the chance 
that we can find an affected cell in a coordinate 
point P(x, y, z). next calculate CILM. 
Next, plot a graph between the cell points 
coordinates and the probability measure assigned 
to this point by the automaton readings and 
analysis. 
To release the medicine and other needed 
material, trigger favorable reactions and aid in 
damage repair and healing of the body. 
Figure 1) Functions, activities and application of the ADIBS 
framework using automata 
Next, plot a graph between the cell point 
coordinates and the probability measure assigned 
to this point by the automaton readings and 
analysis. 
To self-destruct or dissolve in the human body 
as and when needed such that there is no adverse 
impact on the human in any form or manner.  
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Figure-2) The cellular impact probability graph (CIPG) 
The 
Cellular 
Impact 
Probability 
Measure 
or CIPM.  
 
 
 
 
 
 
 
The  
minimum 
value is 0 
and 
maximum 
value is 1. 
Each point P represents an individual cell in the body.  
 
Probability (CIPM) is shown on the y-axis and cell point P on the x axis. 
This graph area shows the cells in the human body that are affected or injured. Also, note 
that the point where the infection of another type exists, a corresponding probability of 
zero is plotted on this CIPM graph for the corresponding cell point. For e.g. in this CIPG 
graph the infected cell at 1000 is of probability zero as it is of different type of infection. 
The same cell point will have a probability of 0.5 in the other infection graph as shown in 
Figure-5). However, the CILM graph will remain the same for all the CIPM graphs. 1 
0 
0.5 
0 1000 10000000000………………………..............∞
While the cell for the point 1000 
has value 0 here, in Figure-5, the  
value for the same cell point is 
0.5  
 1
 
 
   
Horizontal Direction Based Spiral 
Search:- 
1.  Consider the affected cell that was 
recorded as the point of origin O(x, y, z). 
Start looking for the affected cell in a 
spiral fashion, with a movement in 
horizontal direction, starting with the 
boundary made by the affected cell as a 
point. 
2.  If the affected cell was found in that 
position, then give a higher probability 
than the previous affected cell (say add 
.002 to the previous affected cell 
impact), say by a particular factor. This 
is done by in the following ways:- 
2.1. If the earlier affected cell was    
       found closer to the current affected   
       cell, then the probability of the  
       current affected cell must be  
       higher or same as the previous one.  
   2.2. A higher measure may be given to  
          signify a cluster of affected cells in  
          a region.    
   2.3.If the cell not found in that 
position, then the automaton will look 
will horizontally move to next cell (in a 
spiral-like circular fashion, looking for 
cells). When there is more than one 
circle of cells that are being recorded as 
not affected, then we move back to the 
vertical direction based search and the 
algorithm execution control moves back 
to the first step of the latter. 
 
Vertical Direction based Spiral 
Search:- 
1)  Start from the top of the body, the top 
most point in the  human body i.e. 
head and start locating each cell at a 
that point. 
2) If the algorithm has just completed the 
Horizontal direction based spiral 
search and moved the control back 
here, then we get the next point in the 
body in a spiral fashion with a vertical  
direction. 
3) By fetching the samples of and traits to 
identify the affected cell, stored in the 
automaton’s memory compare the 
same with the cell in the human body 
4) If they are similar (in length, width 
and depth along with other traits 
like color) with an accuracy of 70% or 
higher (this accuracy level can be 
increased or decreased as needed), then 
assign a Probability measure out of 
one, for its chance of being an affected 
cell. Generally, affected cells are given 
a rating above 0.5 /1. Next find CILM. 
5) Next, if the comparison gives a 
successful result, and then records all 
details for this human affected cell. 
Then we move to step-b). Else, we go 
to step-5) 
6) Send the details of the current cell P(x, 
y, z) to the external examiners or 
record the answer in the memory. 
Obtain the next cell at point P(x, y, z) 
and move to that location. If there are 
no more points to present to search 
then stop searching and create a graph 
and transmit the details to external 
computer or record in the memory. 
The search process starts. 
The automaton having 
the AE is inserted via 
MOUTH or injection.   
Infected Cell Was 
Found. Now, start 
searching for the 
affected cells in a 
spiral fashion to 
detect infected cell 
clusters.
No more cells found in the spiral fashion and 
probability is constantly below infection levels. 
Thus, start searching again in linear Search.
All the cells in the body have been 
tested, analyzed and studied by the 
automaton. The results are sent via 
sensors as each cell is detected in the 
search process to us. Store the results 
in our database. The automaton self-
destructs without affecting the living 
organism. 
Create the CIPG, CILG graphs and use the medical 
decision-support system to understand the infection 
and suggest repair and solution mechanisms. 
Figure 3) Search mechanism for finding and recording infected cells 
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Figure 4) The cellular Infection Level graph (CILG) 
The 
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The  
minimum 
value is 0 
and 
maximum 
value is 1. 
Each point P represents an individual cell in the body.  
 
The average infection weight (CILM) is shown on y-axis and cell point P on x 
axis. This graph area shows all the cells and the degree of infection present in 
each of them. This also tells us if more than one type of infections are present in 
the body. 
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Figure 5) CIPG graph for second type of infection. 
The 
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Each point P represents an individual cell in the body.  
Probability (CIPM) is shown on the y-axis and cell point P on the x axis.This graph area shows the 
cells in the human body that are affected or injured. For every type of infection found, there will be 
a new CIPM graph drawn. This graph is for the second type of infection found for the example in 
the paper. The graph will be plotted from the cell point where it was encountered. There will one 
CIPG graph for every new infection type. As shown in Figure-2, the corresponding probability for 
that point in all other CIPG graphs for other types of infection will be zero. Also, note that the point 
where the infection exists, a corresponding probability of zero is plotted on the first CIPM graph for 
the corresponding cell point. However, the CILM graph will remain the same for all the CIPM 
graphs. 
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Value of 0.5 for the point 
1000 in this graph is 0.5 
while the same cell has value 
0 in Figure2) 
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Figure 5) the cellular Infection Probability graph (CIPG) for second 
type of infection.
The 
Cellular 
Infection 
Probability  
Measure 
or CIPM.  
Each point P represents an individual cell in the body.  
Probability (CIPM) is shown on the y-axis and cell point P on the x axis.This graph area shows the 
cells in the human body that are affected or injured. For every type of infection found, there will be 
a new CIPM graph drawn. This graph is for the second type of infection found for the example in 
the paper. The graph will be plotted from the cell point where it was encountered. There will one 
CIPG graph for every new infection type. As shown in Figure-2, the corresponding probability for 
that point in all other CIPG graphs for other types of infection will be zero. Also, note that the point 
where the infection exists, a corresponding probability of zero is plotted on the first CIPM graph for 
the corresponding cell point. However, the CIWM graph will remain the same for all the CIPM 
graphs. 
1
0
0.5 
0 1000 10000000000………………………..............
Value of 0.5 for the point 
1000 in this graph is 0.5 
while the same cell has value 
0 in Figure2) 
  
Figure-2) The cellular impact probability graph (CIPG)
The 
Cellular 
Impact 
Probability 
Measure 
or CIPM.  
Each point P represents an individual cell in the body.  
Probability (CIPM) is shown on the y-axis and cell point P on the x axis. 
This graph area shows the cells in the human body that are affected or injured. Also, note 
that the point where the infection of another type exists, a corresponding probability of 
zero is plotted on this CIPM graph for the corresponding cell point. For e.g. in this CIPG 
graph the infected cell at 1000 is of probability zero as it is of different type of infection. 
The same cell point will have a probability of 0.5 in the other infection graph as shown in 1
0
0.5 
0
1000 10000000000………………………..........
While the cell for the point 
1000 has value 0 here, in 
Figure-5, the  
  
Figure-6-a) The human sperm as a possible automaton structure design, 
moving in a host body.  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure- 6-b) The human sperm structure and its components. 
 
Sources:- Mader. Human Biology. 7th Edition. The Mcgraw Hill Companies. 
2001.  
The automaton will have a cover made up of biodegradable material so that it 
can self-destruct easily without causing any problems to the host body.  
The automaton will have a sperm-like 
structure with the head containing the camera, 
radar and processing unit. 
The middle part of the automaton will 
consists of the engine for navigational 
propagation, communication equipment 
and medicinal material to deliver to the 
affected cell. 
The tail will help in locomotion 
and the steering mechanism 
Figure-7) Experiment using NanoHive/HiveKeeper simulation software and 
simulated datasets. 
The experiments were undertaken as mentioned in the methodology section of this 
paper. The automatons used artificially intelligence based learning algorithm called 
IBSEAD for the help in detection using the framework.  As and when obstacles 
were encountered, AIA model tried to avoid the obstacles (as programmed in this 
case. Here, the automatons can be programmed to destroy or put the medicine it 
carries at the obstacle. In this case, the automaton will put the medicine on the 
affected cells only post detection stage. In these scenarios, we have limited the 
experiments to the detection stage only) 
1) Initial Screen of the biological system using NanoHive and  
HiveKeeper: - The point showed by x, y, z coordinates is the automaton. 
The tube like structure is being shown as the biological system in which as a 
certain section is visible here. The simulation was developed in the form of a 
nanotube like structure. The Initial Screen of the NanoHive simulation with 
1 unknown entity is shown below:- 
 
 A similar process was performed for the rest of the test cases and by using 
the obstacle avoidance algorithms. One of the most interesting observations 
was the performance of the models in the presence of unknown entities. The 
use of IBSEAD (Dundas J and Chik D. 2010) helped in improving the 
performance of the AIA model, especially in complex scenarios. 
2) In the next stages, we introduced certain regions as yellow which depicted 
affected cells. The red-coloured object is the obstacle which the automaton 
is avoiding and also collecting information about it as knowledge. The 
automaton tries to detect the affected cells using the framework.   
 
 
 
 
 
The automaton is shown by x,y, and z coordinates. Note that while it is trying to 
avoid the obstacle using its hierarchical motion algorithm, it is also learning and 
collecting information about its obstacle (shown in red circular form between the 
yellow coloured affected regions.
Yellow coloured regions are the affected regions in the biological 
system area. The biological system is the area in the cylindrical pipe. 
Red coloured 
spot is the 
obstacle. Note 
how the black 
coloured 
nano-object 
tries to avoid 
the obstacle 
while the AIA 
based 
automaton 
tries to collect 
its 
information 
too. 
The black 
coloured 
spot is the 
obstacle 
avoiding 
nano-object 
(Hla et al 
Nov 2008)  
Figure-8) Experiment Results using NanoHive/HiveKeeper simulation 
software and simulated datasets. 
Note that:- 
1) Metric B: - Time Taken (which was faster - AIAM or OAM) for detection & 
avoiding the obstacle. 
2) Metric C:- %age of the system’s affected cells detected by OAM 
3) Metric D :- %age of the system’s affected cells detected by AIAM 
4) As OAM is one of the best and common methods used till date, we have 
chosen OAM for our experiments here. 
5) KE stands for known entities and UKE stands for unknown entities 
Description: - The experiments were undertaken as mentioned in the methodology 
section of this paper. 
Remarks: - Clearly from the results, the AIAM gives better performance against 
OAM. The results were quite noteworthy in the case of complex and multiple 
entities, especially for unknown entities. 
Experiment 
Cases 
Were affected cells 
detected using 
Metric B 
(AIAM 
or 
OAM?) 
Metric C Metric D 
Obstacle 
Avoidance 
Model or 
OAM 
AIA 
Model( 
using 
IBSEAD) 
1 KE Yes Yes OAM 62 65 
2 KEs Yes Yes OAM 67 69 
KEs > 10 Yes (with 
lower success 
ratio) 
Yes AIAM 58 71 
1 UKE Yes(with 
lower success 
ratio) 
Yes AIAM 53 74 
2 UKE No or Low Yes AIAM 23 76 
UKE > 10 No or Low Yes AIAM 33 76 
 
 
 
 
 
       
 
 
 
 
 
 
 
 
 
